Metabolism-based Cancer Therapy Symposium 2021
Das 2. Metabolism-based Cancer Therapy Symposium findet am 30. November 2022 statt!
Alle Informationen dazu HIER
Outline 2021
8th October 2021 Metabolism-based Cancer Therapy Symposium #MetaboCancerTherapySymp
In the last decade cancer metabolism has emerged as a cancer hallmark. Although it has been almost a century since Otto Warburg described a difference in cellular metabolism in cancer cells, cancer-specific metabolic alterations have not been fully exploited therapeutically. Increasing numbers of studies showed both the complexity and the promise of targeting metabolism as a therapeutic strategy in cancer. It is time for scientists and clinicians working on this strategy to meet and exchange their experience.
With a translational focus, the symposium brings together oncologists and researchers interested in exploiting the metabolic bias of tumors for therapeutic interventions. It aims to shed light and bring to discussion novel translational approaches that are either currently under clinical testing or show translational potential in preclinical studies.
Speaker
Erika Pearce, Johns Hopkins University, Baltimore
Matthew van der Heiden, MIT Koch Institute for Integrative Cancer Research, Cambridge
Saverio Minucci, European Institute of Oncology and University of Milan
Claudio Vernieri, The FIRC Institute of Molecular Oncology, Milan
Thomas Oellerich, Goethe University,Frankfurt
Julie St-Pierre, University of Ottawa
Michael Pollak, McGill University, Montreal
Programm
8th October 2021 11:30 am - 6 pm (CET), download programm here
11:30 AM - 12:00 AM Tech set up
12:00 PM - 12:10 PM Welcoming Remarks by organizers
|
12:10 |
Session Intro |
| 12:15 |
Exploiting metabolically activated signaling pathways to tackle cancer Prof. Saverio Minucci, European Institute of Oncology, University of Milan |
| 12:45 |
Hypoglycemic diet reshapes systemic metabolism and intratumor immunity in cancer patients Claudio Vernieri, M.D. Ph.D, IFOM - The FIRC Institute of Molecular Oncology, Milan |
| 1:15 |
Elucidation of pathogenic mechanisms in acute myeloid leukemia by integrated proteogenomics Prof. Dr. med. Thomas Oellerich, Goethe University Frankfurt |
| 1:45 | Open discussion |
| 2:00 | Coffee Break |
|
2:25 |
Session Intro |
|
2:30 |
Phosphoinositide acyl chain saturation drives effector CD8+ T cell signaling and anti-tumor immunity Prof. Erika Pearce, Johns Hopkins University, Baltimore |
|
3:00 |
Metabolic adaptations supporting the evolution of resistance to chemotherapeutics in breast cancer Prof. Julie St-Pierre, University of Ottawa |
|
3:30 |
Reduced expression of Electron Transfer Flavoprotein Dehydrogenase provides a growth advantage to cancers but increases sensitivity to oxphos inhibitors Prof. Michael Pollak, MD, McGill University, Montreal |
| 4:00 | Open discussion |
| 4:30 | Coffee break |
4:45 PM - 5:30 PM Keynote How understanding cancer metabolism informs therapy Prof. Matthew van der Heiden, Director, Koch Institute for Integrative Cancer Research
5:30 PM - 6:00 PM Panel Discussion Future directions
Graphical Recordings
made by Scivisto
Graphical Recording of the panel discussion Future Directions
Graphical Recording Keynote Talk by Matthew Wander Heiden
Educational points
The event will be rewarded with 7 SLÄK (sächsische Landesärztekammer) points (only for saxonian physicians).
Organizing Team
Dr. Mohamed Elgendy, Institute for Clinical Chemistry, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden
Dr. med. Ekaterina Balaian, Medical Clinic 1, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden
Prof. Martin Bornhäuser, Medical Clinic 1, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden
Prof. Dr. med. Triantafyllos Chavakis, Institute for Clinical Chemistry, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden
Dr. Peggy Jungke, Scientific and Event coordination at Mildred Scheel Early Career Center Dresden
